info@trade-jp.net
menu
News / Blog
ATTENTION! August Holidays!
21/07/2026
Starting from 11th August to 16th of August there will be local Obon holidays in Japan.
As our hospital and suppliers do not operate,
Catalog
| Product Code |
|
| Availability | 2 |
| Price | USD 249.00 |
| Qty |
Atomoxetine tablets 25 mg for attention-deficit/hyperactivity disorder (ADHD, Strattera)
Product Code :
Availability : 2
USD 249.00
Are Atomoxetine tablets 25 mg effective for the treatment of attention-deficit/hyperactivity disorder (ADHD, Strattera)?
Atomoxetine tablets offer a targeted approach to managing attention-deficit/hyperactivity disorder (ADHD) symptoms, providing relief for individuals struggling with inattention, hyperactivity, or impulsiveness. As a key element in ADHD treatment, these tablets function by regulating neurotransmitters responsible for transmitting information between nerve cells in the brain. This mechanism of action is crucial in addressing the core symptoms associated with ADHD, making atomoxetine tablets a valuable option for those in need of effective management.
One of the notable advantages of atomoxetine tablets is their suitability for a broad age range. Whether for adults grappling with ADHD or children as young as 6 years old, these tablets provide a versatile treatment option that can cater to varying needs across different age groups. This versatility enhances accessibility and ensures that individuals of all ages can benefit from effective ADHD management.
Moreover, the effectiveness of atomoxetine tablets is well-supported by extensive research and clinical trials. Numerous studies have validated the efficacy of the active ingredients in alleviating ADHD symptoms, underscoring the reliability of this treatment option. For instance, in a comprehensive study titled “Safety and Tolerability of Atomoxetine Hydrochloride in a Long-Term, Placebo-Controlled Randomized Withdrawal Study in European and Non-European Adults with Attention-Deficit/ Hyperactivity Disorder”, researchers observed positive outcomes in over 2000 patients across 18 countries. The study demonstrated that atomoxetine exhibited an acceptable safety profile in adults with ADHD, with sustained efficacy even after 1 year of treatment. Importantly, no clinically meaningful safety-related rebound effects were noted following abrupt discontinuation after 24 weeks of treatment, further affirming the favorable risk-benefit profile of atomoxetine tablets.
In conclusion, atomoxetine tablets represent a reliable and effective option for individuals seeking to manage ADHD symptoms. With their ability to target core symptoms and their demonstrated efficacy across diverse age groups, these tablets offer a comprehensive solution for those navigating the challenges of ADHD. Supported by robust research findings, atomoxetine tablets stand as a cornerstone in ADHD treatment, providing hope and relief for countless individuals worldwide.
Package details: 140 tablets
Dosage and administration:
For patients under 18 years old: start this medication at a daily total of 0.5 mg/kg as atomoxetine, then increase to 0.8 mg/kg daily, and subsequently up to 1.2 mg/kg. Maintenance should fall within the range of 1.2 to 1.8 mg/kg per day. Adjustments should occur weekly or longer. In all cases, the medicine should be taken in 2 separate doses daily. Dosage may be tailored based on symptoms, but should not exceed 1.8 mg/kg or 120 mg daily, whichever is lower.
For patients 18 years or older: begin with a total daily dose of 40 mg as atomoxetine, increasing to 80 mg daily, with maintenance ranging from 80 to 120 mg daily. Up to 80 mg, increments should happen weekly or longer, then at intervals of 2 weeks or longer beyond 80 mg. Administer as a single daily dose or divided into two. Dosage adjustments can be made based on symptoms, but should not exceed 120 mg per day.
Each preparation contains 25 mg of atomoxetine. Do not crush or grind the tablet; swallow whole to avoid eye irritation. If particles come into contact with your eyes, rinse with water immediately and seek medical advice. If particles touch your skin, wash thoroughly with water.
Active components: Atomoxetine hydrochloride
Therapeutic effect: the treatment of attention-deficit/hyperactivity disorder (ADHD)
Contraindications and precautions: The medication could induce drowsiness or dizziness. Refrain from driving or operating hazardous machinery following its administration. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.
Do not use in the following cases:
- pregnant or breastfeeding,
- cardiovascular disorder,
- pheochromocytoma or a history of it,
- angle-closure glaucoma.
There are no reviews for this product.
Write a review
Rating
Bad
Good
News
ATTENTION! August Holidays!
21/07/2026
Starting from 11th August to 16th of August there will be local Obon holidays in Japan.
As our hospital and suppliers do not operate, we stop accepting all orders on our website for this period, website shall not allow orders from August 10th evening till Thursday 13th.
We shall start accepting orders online on Friday (Aug 14th), we shall send payment links and reply to emails on Monday (Aug 17th).
We work according to the following schedule:
- We shall not reply to inquiries from Aug 11th to 16th. We shall reply on Aug 17th. If you email us, you will receive auto-reply from our mailbox. Please do not write many emails, your messages may fall to spam.
- We ship most of the orders, placed before Obon Holidays on August 17th - 20th. We shall advise tracking once we ship.
- We shall confirm payments for orders placed during holidays on August 17th and advise.
For orders paid during Obon holidays, delivery may be delayed. Please kindly check in advance.
Thank you for understanding.
JHC